CompletedNot Applicable

A 12 Week Study to Evaluate the Efficacy of an Eye Cream

United States40 participantsStarted 2022-01-01

Plain-language summary

This single center, open-label clinical study was conducted to assess the efficacy and tolerance of a topical eye cream when used over the course of 12 weeks by healthy women with moderate to severe under-eye dark circles, moderate under eye puffiness, and mild fine lines and wrinkles. A total of 37 subjects were enrolled into the study.

Who can participate

Age range35 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Females in good general health * With Fitzpatrick Skin Type I - VI * Moderate to severe under eye dark circles * Moderate undereye puffiness * Mild to moderate fine lines and wrinkles Exclusion Criteria: * Subjects who have used retinol or eye cream / serum 7 days prior to study commencement * Nursing, pregnant, or planning a pregnancy during this study * Having a health condition and / or pre-existing or dormant dermatologic disease on the face

What they're measuring

Change in Investigator Clinical Grading versus Baseline

Timeframe: 12 weeks

Bioinstrumentation: Laser Doppler

Timeframe: 12 weeks

Bioinstrumentation: Chromameter

Timeframe: 12 weeks

Trial details

NCT IDNCT05807620

SponsorRevision Skincare

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-05-01

View on ClinicalTrials.gov More Periorbital Hyperpigmentation trials